• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
FIJ 0.00% 8.3¢

FIJI KAVA LIMITED - Corporate Spotlight

Fiji Kava is a medicinal Noble kava company based in Australia, providing a natural... Fiji Kava is a medicinal Noble kava company based in Australia, providing a natural solution to calm and soothe nerves, support muscle relaxation, increase mind relaxation and induce sleep.More

Corporate Spotlight

Fiji Kava is a medicinal Noble kava company based in Australia, providing a natural solution to calm and soothe nerves, support muscle relaxation, increase mind relaxation and induce sleep.
View the full Corporate Spotlight arrow Created with Sketch.

VIABILITY OF KAVA IN HEALTHCARE

arrow-down-2 Created with Sketch.

28th July 2020 - The Market Herald


  • A muscle relaxing drink from the Pacific Islands could be seeing a resurgence in the alternative medicine market
  • The drink called Kava is taken from a plant's root and can be used in curbing anxiety and give feelings of euphoria
  • Australian listed company Fiji Kava (ASX:FIJ) is trying its best to catch the wave that is seeing kava put in bars, clubs, alternative dining, and in fringe culture
  • Fiji Kava signed on a new deal with natural medicine supplier Oborne Health Supply today — which will see further distribution of its Kava properties in pill form
  • Shares in small cap Fiji Kava have achieved a valuation of 10.5 cents each after a five per cent premium today

A Pacific Island muscle relaxant drink has made its way into fringe culture, bars, and even healthcare investors' hands. But how viable is it in the greater market?


Chances are you haven't crossed paths with the niche alternative medicine. The root of the plant is used in creating a thick-textured drink.


When consumed, a kava drinker experiences muscle relaxation, sedation, anaesthetic effects, and feelings of euphoria. Kava is also known to provide measures in combatting depression and anxiety.


For many years, curious globetrotters would have to visit the Pacific Islands in person to get a taste.

However, the past decade has seen the properties of kava marketed to greater western consumers through sprays and even pill forms.


A stand out in the Australian market has flashed its teeth — Fiji Kava.


The small cap company most recently closed shares at 11 cents each in a $6.97 million valuation — pushing the muscle relaxant properties in a pill form.


According to Fiji Kava, the global alternative medicine market is expected to reach a roughly $310 billion valuation by 2026. The company is looking to break into this market with its choice of kava strain known as "Noble".


"There is a major resurgence of global demand for kava, with unprecedented interest shown in our Noble kava extracted products in capsule and powdered forms," Fiji Kava Founder and Managing Director Zane Yoshida said.


Fiji Kava Founder Zane Yoshida
Image sourced from Youtube

Kava is commonly grouped into two major categories: Noble and Tudei.


Tudei kava is referred to as being much stronger than Noble kava and more likely to cause drinkers nausea and overwhelming sensations.


Fiji Kava is the first foreign company in the industry to gain approval from the Fijian Government. Today it operates a tissue culture lab and a 111-acre farm on Fiji's Ovalau island.


Recently Fiji Kava got major recognition from the Australian Government, softening trade restrictions on the alternative medicine.


The Fijian island of Ovalau

"The recent relaxation on kava imports by the Australian Federal government further supports this resurgence," Zane said.


Now the Fiji Kava pills are even being sold through popular web-shop Amazon.


Today the company ear marked its latest accomplishment, signing a memorandum with an Australian natural health market leader — Oborne Health Suppliers.


"We selected Oborne Health Suppliers based on their leadership and wholistic offering, and we are confident that together we can deliver customer service and support at both an individual retailer and key retail banners nationally across the Natural, Traditional and Complementary Health channel," Zane added.


Oborne distributes its repertoire of natural medicines to health practitioners, health food stores and anything in between.

This deal will act as a gateway for Fiji Kava to reaching further naturopaths, specialists, herbalists, doctors, and chiropractors.


Oborne Health boasts 29 years of experience in the industry and sources products from over 300 suppliers.

Oborne Health Supplies Director Barry Oborne had words of encouragement to add today.


"We are very excited to be working with Fiji Kava, and be distributing their products across our national network of healthcare professionals, to meet the growing demand for kava within our network," he said.


Shares in Fiji Kava have undergone a 10 per cent premium today to trade at an even 11 cents each.


28th July 2020 - The Market Herald

FIJ PARTNERS WITH PHAMA PLUS PROGRAM

arrow-down-2 Created with Sketch.

7th July 2020 - The Market Herald


  • Fiji Kava (FIJ) has partnered with the Pacific Horticultural and Agricultural Market Access (PHAMA) Plus Program to strengthen kava export opportunities 
  • Fiji Kava's subsidiary, South Pacific Elixirs, will work with PHAMA Plus to boost the sustainable production and distribution of kava from Fiji
  • The partnership will also see South Pacific Elixirs and PHAMA Plus work on design and installation of commercial kava nurseries in Fiji
  • This is to sustainably mass-produce kava root to meet the growing market
  • Noble kava has proven medicinal and relaxation benefits and the global market is expected to exceed US$210 billion by 2026
  • Company shares have risen 3.85 per cent and are trading for 8.1 cents each

Fiji Kava (FIJ) has partnered with the Pacific Horticultural and Agricultural Market Access (PHAMA) Plus Program to strengthen kava export opportunities.


Fiji Kava's subsidiary, South Pacific Elixirs, will work with PHAMA Plus to ensure the high-quality, sustainable commercial production and distribution of Fijian kava to global export markets.


This includes utilising the company's tissue culture lab, which is a world-first used to propagate disease-free plants.

"Fiji Kava's world-first tissue culture laboratory and its network of hundreds of local Fijian farmers ensures that our supply chain is uniquely positioned to support this marquee initiative between the two countries," Fiji Kava Founder and CEO Zane Yoshida said.

Fiji Kava is an Australian-Fijian medicinal kava company that produces natural 'noble kava' products.


There are two types of kava — non-noble and noble. In Fiji, only noble kava can be found and is commonly used for its medicinal and relaxation benefits. 


Unlike its non-noble counterpart, noble kava is perfectly safe for consumption and doesn't contain a high concentration of harmful chemicals. Noble kava, especially when the root is extracted using a freshwater method, reduces the chance of negative side effects such as nausea.


"It's an honour to be chosen as the inaugural Fijian partner for the PHAMA Plus program in Fiji. We recognise the importance of this partnership to the Fijian kava community and the major opportunity which exists to export our high-quality, disease-free kava supply around the world," Zane said.


South Pacific Elixirs and PHAMA Plus will partner on design, procurement and installation of commercial kava nurseries in Fiji. Initially, two nurseries in Ovalau and Vanua Levu will be established.


These nurseries will be optimised for the mass production of kava plants which will be distributed to the subsidiary's network of contracted farmers.


This is set to meet the growing global demand for kava, which is expected to exceed US$210 billion (roughly A$301.3 billion) by 2026. 

"Improving the quality of kava is a priority for PHAMA Plus and by partnering with an established leader in the Fijian kava industry, we are able to more effectively progress the significant export opportunities that exist across international markets for higher volumes of noble kava to benefit both exporters and local growers," PHAMA Plus National Export Market Systems Facilitator Navitalai Tuivuniwai said.


The partnership will also focus on sustainable agricultural practices. Initiatives will be implemented to strengthen South Pacific Elixirs' supply chain. 


These initiatives include climate resilience technologies, production planning, expanding capacity, technology transfer, harvesting schedules, quality certification and overall standardisation. 


This partnership has also been backed by the Australian Government, who recognises the importance of the Fijian kava industry and its social and economic importance to the nation's agriculture.


Company shares have risen 3.85 per cent and are trading for 8.1 cents each at 10:48 am AEST.


7th July 2020 - The Market Herald

ABOUT FIJI KAVA

arrow-down-2 Created with Sketch.

Fiji Kava is a medicinal Noble kava company based in Australia, providing a natural solution to calm and soothe nerves, support muscle relaxation, increase mind relaxation and induce sleep. Fiji Kava is the first and only foreign company with approval from the Fijian Government to operate in the kava industry and is the world’s first listed kava company (ASX:FIJ).


The Company has complete control over its vertically integrated supply chain, in a true farm-to-shelf operation and has established an 111-acre “Nucleus Farm” in Levuka, on the island of Ovalau, Fiji. The high-quality Noble kava cultivars that Fiji Kava grows, harvests and processes, are among the most consistent and finest in the world, with few – if any – who can achieve kava at this level.



Widely recognised as supplying the world’s most trusted Noble kava, Fiji Kava is now focused on bringing the secret elixir of Fiji’s world-famous joyful, calm and relaxed culture to the world by distributing a range of scientifically researched, TGA and FDA compliant Noble kava extract products throughout western markets.


 In Australia, this includes Noble kava extract capsules, whereas in Fiji, New Zealand and the United States of America, the range also includes instant powders and shots (with new exciting products currently undergoing development and testing).


In Fiji, Fiji Kava also operates under the Taki Mai brand (with its inception in 2014) with stockists, to name a few,  including Tappoo and Jacks of Fiji.


 


FIND RELIEF TODAY!

The medicinal benefits of kava have been traditionally used in Pacific Islander and Western herbal medicine to promote sleep, relax the body and calm and soothe the nerves.


Our kava possesses specific % levels of kavalactones and other desirable profiles found from our 13 years of research into 200 varieties of kava across the South Pacific.


As well as being TGA and FDA compliant and listed as a complementary medicine in Australia, kava is also sold as a dietary supplement in most other international markets.


Add to Cart

 Browse Shop


Visit Fiji Kava's Website Here

(20min delay)
Last
8.3¢
Change
0.000(0.00%)
Mkt cap ! $7.907M
Open High Low Value Volume
0.0¢ 0.0¢ 0.0¢ $0 0

Buyers (Bids)

No. Vol. Price($)
1 50000 8.2¢
 

Sellers (Offers)

Price($) Vol. No.
8.9¢ 50000 1
View Market Depth
Last trade - 11.27am 05/08/2020 (20 minute delay) ?
FIJ (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.